Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Transcranial Magnetic Stimulation Treatment for Smoking Cessation: An Introduction for Primary Care Clinicians.

Tytuł:
Transcranial Magnetic Stimulation Treatment for Smoking Cessation: An Introduction for Primary Care Clinicians.
Autorzy:
Young JR; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute (DCRI), Duke University School of Medicine, Durham, NC; Mid-Atlantic Mental Illness Research, Education, and Clinical Center (MIRECC), Durham Veterans Affairs Health Care System, NC; Durham Veterans Affairs Health Care System, NC. Electronic address: .
Galla JT; Department of Psychology and Neuroscience, Trinity College of Arts and Sciences, Duke University, Durham, NC.
Appelbaum LG; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; Center for Cognitive Neuroscience, Duke University, Durham, NC.
Źródło:
The American journal of medicine [Am J Med] 2021 Nov; Vol. 134 (11), pp. 1339-1343. Date of Electronic Publication: 2021 Aug 15.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review
Język:
English
Imprint Name(s):
Publication: New York, NY : Excerpta Medica
Original Publication: New York, Donnelly.
MeSH Terms:
Primary Health Care*
Smoking Cessation/*methods
Tobacco Use Disorder/*therapy
Transcranial Magnetic Stimulation/*methods
Humans ; Psychotherapy ; Smoking Cessation Agents/therapeutic use
References:
Addiction. 2009 Apr;104(4):653-60. (PMID: 19183128)
Biol Psychiatry. 2014 Nov 1;76(9):742-9. (PMID: 25038985)
Front Neurol. 2015 Oct 26;6:210. (PMID: 26579065)
Brain Stimul. 2015 Nov-Dec;8(6):1168-74. (PMID: 26590478)
Am J Prev Med. 2015 Mar;48(3):326-33. (PMID: 25498551)
Epilepsy Behav Case Rep. 2016 Mar 16;5:52-6. (PMID: 27114902)
Front Hum Neurosci. 2018 Sep 24;12:344. (PMID: 30319373)
Am J Med. 2008 Apr;121(4 Suppl 1):S3-10. (PMID: 18342164)
Clin Neurophysiol. 2021 Jan;132(1):269-306. (PMID: 33243615)
eNeuro. 2020 Jan 7;7(1):. (PMID: 31848209)
Biol Psychiatry. 2013 Apr 15;73(8):714-20. (PMID: 23485014)
Brain Stimul. 2014 Mar-Apr;7(2):226-33. (PMID: 24468092)
J Clin Psychiatry. 2003 Aug;64(8):951-3. (PMID: 12927012)
Psychiatry Res. 2019 Nov;281:112562. (PMID: 31521838)
Pharmacol Rev. 2018 Jul;70(3):661-683. (PMID: 29945899)
Brain Stimul. 2020 Sep - Oct;13(5):1271-1279. (PMID: 32534252)
Eur Addict Res. 2014;20(5):248-53. (PMID: 24924851)
Biol Psychiatry. 2000 Dec 15;48(12):1133-41. (PMID: 11137053)
Biol Psychiatry. 2011 Oct 15;70(8):794-799. (PMID: 21762878)
Grant Information:
IK1 CX002187 United States CX CSRD VA; U01 AG050618 United States AG NIA NIH HHS
Contributed Indexing:
Keywords: Addiction; Smoking cessation; TMS; Tobacco; Transcranial magnetic stimulation
Substance Nomenclature:
0 (Smoking Cessation Agents)
Entry Date(s):
Date Created: 20210818 Date Completed: 20211206 Latest Revision: 20240214
Update Code:
20240214
PubMed Central ID:
PMC8607981
DOI:
10.1016/j.amjmed.2021.06.037
PMID:
34407423
Czasopismo naukowe
Tobacco use remains the number one preventable cause of death in the United States, resulting in significant public health and economic costs. Despite progress in reducing tobacco use through pharmacotherapy and psychotherapy smoking cessation interventions, additional treatment options are still needed to improve treatment effectiveness. As an adjunctive treatment, the US Food and Drug Administration recently cleared transcranial magnetic stimulation (TMS), a noninvasive brain stimulation technique, as an aid for smoking cessation in adults. Given that most smoking cessation interventions occur in the primary care setting, this article aims to introduce TMS, to provide an overview of the evidence of TMS for smoking cessation, and to outline the procedures for implementing TMS in the primary care setting when referral to an interventional psychiatrist is not possible. With growing scientific evidence and increasing regulatory approval of TMS for smoking cessation, this novel treatment option is now available for patients who want to quit smoking but have been unsuccessful with pharmacologic approaches.
(Published by Elsevier Inc.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies